Search

Displaying results 6181 - 6190 of 7687 in total
  1. Drug

    Demelverine

    go.drugbank.com/drugs/DB20956
    Experimental

    Demelverine has a monoisotopic molecular weight of 239.17 Da.

  2. Drug

    Sipatrigine

    go.drugbank.com/drugs/DB21032
    Experimental

    Sipatrigine has a monoisotopic molecular weight of 371.05 Da.

  3. Drug

    Nemazoline

    go.drugbank.com/drugs/DB21115
    Experimental

    Nemazoline has a monoisotopic molecular weight of 243.03 Da.

  4. Drug

    Ebrotidine

    go.drugbank.com/drugs/DB21220
    Experimental

    Ebrotidine has a monoisotopic molecular weight of 475.98 Da.

  5. Drug

    Aloracetam

    go.drugbank.com/drugs/DB21233
    Experimental

    Aloracetam has a monoisotopic molecular weight of 208.12 Da.

  6. Drug

    Adarigiline

    go.drugbank.com/drugs/DB21418
    Experimental

    Adarigiline has a monoisotopic molecular weight of 360.08 Da.

  7. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    Oxmetidine has a monoisotopic molecular weight of 399.14 Da.

  8. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    Tisolagiline has a monoisotopic molecular weight of 322.13 Da.

  9. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    Mosperafenib has a monoisotopic molecular weight of 461.1 Da.

  10. Drug

    OXI-4503

    go.drugbank.com/drugs/DB05143
    Investigational

    OXI-4503 (combretastatin A1 di-phosphate / CA1P) is a unique and highly potent, dual-mechanism vascular disrupting agent (VDA). … addition, however, preclinical data demonstrates that OXI-4503 is metabolized by oxidative enzymes (e.g., tyrosinase and peroxidases), which are elevated in many solid tumors and tumor infiltrates, to an